Klaassen Doriann, Mok Shinghei, Hwang Jenie Y, Blount Sydney L, Williams Kelley J, Fong Brendan M, Chicoine Michael R, Dacey Ralph G, Farrell Nyssa F, Osbun Joshua W, Rich Keith M, Roland Lauren T, Schneider John S, Zipfel Gregory J, Luo Chongliang, Kim Albert H, Silverstein Julie M
Division of Endocrinology, Metabolism, and Lipid Research, Washington University School of Medicine, St. Louis, Missouri, USA.
Department of Neurological Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Neuro Oncol. 2025 Sep 8;27(7):1746-1757. doi: 10.1093/neuonc/noaf069.
Readmission following endoscopic endonasal transsphenoidal surgery (EETS) for pituitary neuroendocrine tumor (PitNET) and other sellar pathology is most commonly due to delayed hyponatremia. Studies suggest postoperative fluid restriction (FR) reduces delayed hyponatremia. We present a prospective randomized controlled study evaluating post-EETS FR.
300 participants were scheduled for EETS (2016-2023) at a single institution. Patients with CKD, CHF, arginine vasopressin deficiency on postoperative day (POD) 3, chronic hyponatremia, and untreated adrenal insufficiency or hypothyroidism were excluded. Groups included control (ad-lib, n = 94), moderate FR (1.8 L/day or 2 L/day weight > 100 kg, n = 39), and strict FR (1 L/day or 1.2 L/day weight > 100 kg, n = 62) from POD 3-14. Incidence of overall, moderate, and severe hyponatremia (Na < 135, 125-129, and <125 mEq/L), readmission rates, fluid intake, and thirst were evaluated.
The incidence of overall hyponatremia was 31.9%, 28.2%, and 21.0% in control, moderate FR, and strict FR groups, and the incidence of severe hyponatremia was 7.4%, 5.1%, and 0% in control, moderate FR, and strict FR groups. Nadir Na level was higher (1.81 mEq/L; 95% CI, 0.34 to 3.27; P = .02) and severe hyponatremia occurred less frequently (95% CI, 0.00 to 1.02; P = .04) in the strict FR vs. control group. Readmission was lower in the strict FR (1.6%, n = 1) vs. control group (6.4%, n = 6).
Postoperative FR decreases rates of delayed hyponatremia and related readmission compared to patients drinking ad-lib. Further studies are needed to assess the optimal volume and duration of FR after EETS. Trial registration number: NCT03636568.
垂体神经内分泌肿瘤(PitNET)及其他鞍区病变经鼻内镜经蝶窦手术(EETS)后再入院,最常见的原因是迟发性低钠血症。研究表明,术后液体限制(FR)可降低迟发性低钠血症的发生率。我们开展了一项前瞻性随机对照研究,以评估EETS术后的FR。
300名参与者于2016年至2023年在一家机构接受EETS手术。排除患有慢性肾脏病(CKD)、充血性心力衰竭(CHF)、术后第3天精氨酸加压素缺乏、慢性低钠血症以及未治疗的肾上腺功能不全或甲状腺功能减退的患者。分组包括对照组(自由饮水,n = 94)、中度FR组(体重>100 kg者为1.8 L/天或2 L/天,n = 39)和严格FR组(体重>100 kg者为1 L/天或1.2 L/天,n = 62),从术后第3天至第14天。评估总体、中度和重度低钠血症(血钠<135、125 - 129和<125 mEq/L)的发生率、再入院率、液体摄入量和口渴情况。
对照组、中度FR组和严格FR组总体低钠血症的发生率分别为31.9%、28.2%和21.0%,重度低钠血症的发生率分别为7.4%、5.1%和0%。与对照组相比,严格FR组的最低血钠水平更高(1.81 mEq/L;95%置信区间,0.34至3.27;P = 0.02),重度低钠血症的发生频率更低(95%置信区间,0.00至1.02;P = 0.04)。严格FR组的再入院率(1.6%,n = 1)低于对照组((6.4%,n = 6)。
与自由饮水的患者相比,术后FR可降低迟发性低钠血症的发生率及相关再入院率。需要进一步研究以评估EETS术后FR的最佳量和持续时间。试验注册号:NCT03636568。